Unknown

Dataset Information

0

Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes.


ABSTRACT: There is compelling clinical literature implicating a role for cytokines in the pathophysiology of major depressive disorder (MDD). Interleukin-6 (IL-6) and interleukin-1? (IL-1?) are pleiotropic inflammatory cytokines that have been reported to be elevated in patients with MDD. The present studies were undertaken to investigate the relationship between IL-6 and IL-1? in animal models of depressive-like behavior. Analysis of brain tissue homogenates in the cortex of rats subjected to chronic stress paradigms revealed elevated levels of IL-6 protein in the absence of elevations in IL-1?. Central administration of recombinant mouse IL-6 produced depressive-like phenotypes in mice, which were not accompanied by IL-1?-induced increases in the brain tissue or IL-1?-related sickness behavior typical of a general central nervous system inflammatory response. Systemic administration of fluoxetine in the presence of centrally administered IL-6 failed to produce the expected antidepressant-like response in mice relative to sham-infused controls. Further, administration of fluoxetine to mice with endogenous overexpression of brain IL-6 (MRL/MpJ-Fas(LPR/LPR) (LPR mice)) failed to produce the expected antidepressant-like effect relative to fluoxetine-treated control mice (MRL/MpJ(+/+)). Interestingly, blockade of IL-6 trans-signaling by coadministration of a gp130/Fc monomer or an anti-mouse IL-6 antibody with IL-6 prevented the IL-6-induced increases in immobility time as well as attenuated IL-6-induced increases of protein in the cortex. Taken together, these data indicate that elevations in IL-6 may have a pathophysiological role underlying depression and more specifically resistance to current classes of antidepressant medications and suggest that modulation of the IL-6 signaling pathway may have therapeutic potential for treatment-resistant depression.

SUBMITTER: Sukoff Rizzo SJ 

PROVIDER: S-EPMC3565187 | biostudies-literature | 2012 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes.

Sukoff Rizzo S J SJ   Neal S J SJ   Hughes Z A ZA   Beyna M M   Rosenzweig-Lipson S S   Moss S J SJ   Brandon N J NJ  

Translational psychiatry 20121204


There is compelling clinical literature implicating a role for cytokines in the pathophysiology of major depressive disorder (MDD). Interleukin-6 (IL-6) and interleukin-1β (IL-1β) are pleiotropic inflammatory cytokines that have been reported to be elevated in patients with MDD. The present studies were undertaken to investigate the relationship between IL-6 and IL-1β in animal models of depressive-like behavior. Analysis of brain tissue homogenates in the cortex of rats subjected to chronic str  ...[more]

Similar Datasets

| S-EPMC5809383 | biostudies-literature
| S-EPMC7526443 | biostudies-literature
| S-EPMC3552041 | biostudies-literature
| S-EPMC4208806 | biostudies-literature
2017-02-18 | GSE93898 | GEO
| S-EPMC5455063 | biostudies-literature
| S-EPMC6098104 | biostudies-literature
| S-EPMC6961497 | biostudies-literature
| S-EPMC8630574 | biostudies-literature
| S-EPMC10459424 | biostudies-literature